Abstract
Background
To assess the feasibility of biventricular SAPPHIRE T1 mapping in vivo across field strengths using diastolic, systolic and dark-blood (DB) approaches.
Methods
10 healthy volunteers underwent same-day non-contrast cardiovascular magnetic resonance at 1.5 Tesla (T) and 3 T. Left and right ventricular (LV, RV) T1 mapping was performed in the basal, mid and apical short axis using 4-variants of SAPPHIRE: diastolic, systolic, 0th and 2nd order motion-sensitized DB and conventional modified Look-Locker inversion recovery (MOLLI).
Results
LV global myocardial T1 times (1.5 T then 3 T results) were significantly longer by diastolic SAPPHIRE (1283 ± 11|1600 ± 17 ms) than any of the other SAPPHIRE variants: systolic (1239 ± 9|1595 ± 13 ms), 0th order DB (1241 ± 10|1596 ± 12) and 2nd order DB (1251 ± 11|1560 ± 20 ms, all p < 0.05). In the mid septum MOLLI and diastolic SAPPHIRE exhibited significant T1 signal contamination (longer T1) at the blood-myocardial interface not seen with the other 3 SAPPHIRE variants (all p < 0.025). Additionally, systolic, 0th order and 2nd order DB SAPPHIRE showed narrower dispersion of myocardial T1 times across the mid septum when compared to diastolic SAPPHIRE (interquartile ranges respectively: 25 ms, 71 ms, 73 ms vs 143 ms, all p < 0.05). RV T1 mapping was achievable using systolic, 0th and 2nd order DB SAPPHIRE but not with MOLLI or diastolic SAPPHIRE. All 4 SAPPHIRE variants showed excellent re-read reproducibility (intraclass correlation coefficients 0.953 to 0.996).
Conclusion
These small-scale preliminary healthy volunteer data suggest that DB SAPPHIRE has the potential to reduce partial volume effects at the blood-myocardial interface, and that systolic SAPPHIRE could be a feasible solution for right ventricular T1 mapping. Further work is needed to understand the robustness of these sequences and their potential clinical utility.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12880-022-00843-0.
Keywords: T1 mapping, Cardiovascular magnetic resonance, SAPPHIRE, MOLLI
Background
The myocardial longitudinal relaxation time, T1 is a sensitive imaging biomarker for heart muscle disease, linked to both functional capacity and mortality [1–5]. Various techniques have been proposed to quantify T1 relaxation (Fig. 1), each with its own advantages and limitations [6]. One of the main issues of commonly-used T1 mapping techniques is the partial volume effect that can artifactually increase the myocardial T1 times of voxels located at the myocardial-blood pool interface due to confounding by the higher native T1 signal of the blood pool. This is most apparent in cross sectional imaging and its effects are especially detrimental to the study of thin-walled cardiac structures, notably the right ventricular (RV) free wall, atrial walls and the thinned myocardium in dilated cardiomyopathy [7, 8]. Partial volume effects are problematic because they reduce the accuracy and reproducibility of T1 mapping. To overcome this problem in the right and left ventricles (LV), systolic readouts have been proposed [9, 10], as it was hypothesized that the increased myocardial wall thickness during systole would increase the abundance of myocardial voxels that were free from partial volume effects. Systolic readouts collect data during a limited quiescent time window and therefore necessitate a shorter acquisition time to reduce temporal blurring, however this trade off could affect precision. In spite of this limitation, systolic T1 mapping approaches have potential advantages in arrhythmia and resulted in more evaluable images [9–11].
The modified Look-Locker inversion recovery (MOLLI) sequence is still the most commonly used T1 mapping approach in clinical practice due to its widespread availability across vendors and superior precision and reproducibility [12]. Being an inversion recovery-based approach, it is vulnerable to the aforementioned partial volume effects, as well as to off-resonance artifacts, and confounding contributions by magnetisation transfer and T2 effects [11].
A T1 mapping sequence that combines saturation recovery and inversion recovery approaches, termed SAPPHIRE–SAturation Pulse Prepared Heart-rate independent Inversion REcovery–has recently been shown to have potential advantages in arrhythmia [13]. A further refinement to SAPPHIRE that provides blood suppression resulting in dark-blood (DB) native myocardial T1 mapping has shown additional promise at addressing the problem of myocardial signal contamination from the adjacent blood pool [8]. DB SAPPHIRE potentially measures more accurate T1 than the conventional diastolic SAPPHIRE because of less contamination from the blood pool signal, but this is at the expense of precision.
Here we undertake a head-to-head comparison of SAPPHIRE T1 mapping variants across field strengths. We assess the performance of LV and RV SAPPHIRE T1 mapping in vivo considering 4 variants: diastolic, systolic, 0th and 2nd order DB SAPPHIRE, and compare results to those obtained by conventional MOLLI across field strengths.
Methods
All subjects provided written informed consent. The study received ethical approval from the University College London (UCL) Research Ethics Committee (Project number 6782/001) and it conformed to the principles of the Helsinki Declaration.
Study population and data collection
In this prospective single-center observational study, 10 healthy volunteers underwent non-contrast cardiovascular magnetic resonance (CMR) scanning at both field strengths on the same day at the UCL Bloomsbury Center for Clinical Phenotyping (London, UK). Volunteers had no prior cardiac history or known cardiac risk factors, were not on cardiovascular medications, had a normal resting electrocardiogram (ECG), and were free of conventional contra-indications for CMR.
Cardiovascular magnetic resonance
CMR studies were performed using two Siemens MR systems (Erlangen, Germany): MAGNETOM AERA 1.5 Tesla (T) operating VE11C-SP01 and MAGNETOM PRISMA 3 T operating VE11C-SP01, with 18-channel phased-array chest coils. The scan protocol was identical for the two field strengths and consisted of localizers, transaxial black blood HASTE anatomical stack, breath-held retrospectively ECG-gated balanced steady-state free precession (bSSFP) cines in standard long and short axis views [14], and then breath-held ECG-gated T1 mapping in the basal, mid and apical LV short axis slices (co-registered with the cines) using MOLLI with motion correction (MOCO), bright-blood diastolic SAPPHIRE, bright-blood systolic SAPPHIRE, 0th order DB SAPPHIRE and 2nd order DB SAPPHIRE in random order per scan. To minimize off-resonance artifacts with higher field strengths, the 3 T protocol additionally included frequency scouts and attention to volumetric shimming.
Typical imaging parameters for the T1 mapping sequences are summarised in Table 1.
Table 1.
TR/TE (ms) | TD (ms) | FA | TI (ms) | Matrix | Slice thickness (mm) | FOV (mm) | Pixel size (mm) | Aquisition window (ms) | ||
---|---|---|---|---|---|---|---|---|---|---|
MOLLI | 1.5 T | 291.84/1.22 | 605 | 35° | ~ 103–4035 | 256 × 192 | 8 | 300 × 225 | 1.171875 × 1.171875 | 4 |
3 T | 283.8/1.16 | 780 | 20° | ~ 103–4438 | 256 × 192 | 8 | 300 × 225 | 1.171875 × 1.171875 | 4 | |
Diastolic SAPPHIRE | 1.5 T | 830/1.12 | 710 | 70° | ~ 715 | 256 × 192 | 8 | 300 × 225 | 1.171875 × 1.171875 | 8 |
3 T | 856/1.12 | 778 | 68° | ~ 740 | 256 × 192 | 8 | 300 × 225 | 1.171875 × 1.171875 | 8 | |
Systolic SAPPHIRE | 1.5 T | 830/1.12 | 315 | 70o | ~ 335 | 256 × 192 | 8 | 300 × 225 | 1.171875 × 1.171875 | 9 |
3 T | 857/1.12 | 393 | 68o | ~ 380 | 256 × 192 | 8 | 300 × 225 | 1.171875 × 1.171875 | 9 | |
DB 0th order SAPPHIRE┼ | 1.5 T | 800/1.28 | 678 | 70o | ~ 670 | 256 × 192 | 8 | 300 × 225 | 1.171875 × 1.171875 | 7 |
3 T | 857/1.12 | 753 | 68 | ~ 740 | 256 × 192 | 8 | 300 × 225 | 1.171875 × 1.171875 | 7 | |
DB 2nd order SAPPHIRE┼ | 1.5 T | 800/1.28 | 678 | 70o | ~ 670 | 256 × 192 | 8 | 300 × 225 | 1.171875 × 1.171875 | 8 |
3 T | 857/1.12 | 750 | 68o | ~ 740 | 256 × 192 | 8 | 300 × 225 | 1.171875 × 1.171875 | 8 |
DB, Dark blood; FA, flip angle; FOV, Field of view; MOLLI, Modified Look-Locker inversion recovery; SAPPHIRE, SAturation Pulse Prepared Heart-rate independent Inversion Recovery; T, Tesla; TD trigger delay; TI inversion time; TR/TE, time between two consecutive excitations/ echo time
10 images acquired with 10 s breath-hold duration and 125 encoding steps for all sequences
┼MSDE gradient amplitude 20 mT/m with preparation duration 10 ms
Cardiovascular magnetic resonance analysis
Images were analysed using CVI42 software (Circle Cardiovascular Imaging Inc. v.5.10.1, Calgary, Canada). Measurements were performed by two readers with over three years of advanced cardiac MRI experience (M.A., J.A.). LV volumes, LV ejection fraction (LVEF) and mass were determined according to standardized CMR methods [15] using a semiautomated threshold-based technique and body surface area (BSA) indexation where appropriate. Atrial volumes, LV maximal wall thickness, and mitral and tricuspid annular plane systolic excursions were determined as previously described [16–18].
For native T1 measurements in the LV, endo- and epicardial borders were manually drawn per segment according to the 16-segment American Heart Association model, in the 3 short axis slices (10% offset). Segmental T1 times were averaged to obtain the mean slice T1 and global T1 calculated as the mean of basal, mid and apical LV short axis slices.
As demonstrated in Fig. 2 the RV region of interest (ROI) measurements were obtained from the RV inferior wall or free wall in the basal or mid short axis slices if wall thickness ≥ 5 mm.
The transeptal myocardial T1 times for MOLLI and SAPPHIRE variants were calculated in OsiriX MD using six evenly-spaced points along linear callipers transecting the mid-septal short axis slice on the T1 maps of each healthy volunteer.
Intra- and inter-observer re-read variability was determined for measurements of average mid slice T1, and mid septal ROI T1 in 5 randomly chosen CMR scans. Intra-observer variability was performed with one-month temporal interval between repeat analyses.
Native SAPPHIRE T1 mapping sequences
Diastolic SAPPHIRE
Conventional diastolic SAPPHIRE (without any attempt to suppress the blood signal, i.e. ‘bright blood’) consists of a combination of saturation and inversion pulses. A saturation pulse is applied immediately after the R wave followed by an inversion pulse inserted in the same heartbeat prior to image acquisition (Fig. 3a). The first image acquisition is done without magnetisation preparation.
Systolic SAPPHIRE
Systolic SAPPHIRE also consists of saturation and inversion recovery magnetisation preparation hybrid and 10-ECG triggered readouts but data is acquired during systole, and with shorter acquisition windows than the diastolic SAPPHIRE. Imaging in systole is challenging due to the short time window available between R waves resulting in a weak saturation recovery T1 mapping signal. As a fix, saturation is performed in the preceding heart-beat directly following the imaging pulses played in the previous heart-beat. Similar to diastolic SAPPHIRE, the first image is acquired without magnetisation preparation. The remaining images are obtained with an extra inversion pulse with variable delay following the R wave (Fig. 3b).
0th and 2nd Order dark blood diastolic SAPPHIRE
DB T1 mapping is achieved using a modified SAPPHIRE technique [19]. For blood suppression, motion sensitized driven equilibrium (MSDE) preparation is inserted before the bSSFP imaging readout (Fig. 4a). The MSDE preparation consists of a 90° excitation tip-down pulse, a one or more 180° refocusing pulse, and a –90° flip-back pulse to encode the spin dephasing in the longitudinal magnetisation (Fig. 4a). Strong motion sensitising gradients are also sandwiched in between the radiofrequency pulses to induce dephasing. Two kinds of motion sensitising gradients are employed, with nulling the gradient moment up to the 0th and 2nd order respectively. To achieve 0th order gradient nulling, identical trapezoidial gradients are played before and after the refocusing pulse.
Additionally, in this study advanced motion sensitising gradients were introduced. As illustrated in Fig. 4b, reverse bipolar gradient blips are inserted to achieve 0th and 2nd moment nulling.
Data analysis and statistics
Statistical analysis was performed in R programming language (version 3.6.0, The R Foundation for Statistical Computing) and SPSS statistical software (version 26.0, IBM Corp., Armonk, NY, USA). Descriptive data are expressed as mean ± standard deviation except where otherwise stated. The distribution of data was evaluated by histograms and Shapiro–Wilk test. Parametric and nonparametric continuous variables pertaining to participants were compared using student t-test or Mann–Whitney U test as appropriate. Categorical variables were compared by χ2 or Fisher’s exact tests.
Linear mixed effect models were used to compare T1 times across SAPPHIRE techniques (fixed effects: e.g. systolic vs. diastolic, 1.5 T vs. 3 T, slice level) accounting for repeatedness (random effect: subject ID). In addition, paired-samples t-test (parametric) or related-samples Wilcoxon signed rank test (non-parametric) were used for pairwise comparisons between MOLLI and SAPPHIRE, and within SAPPHIRE, across field strengths using Bonferroni correction.
Differences in transeptal T1 mapping profiles between sequences were assessed using two samples Anderson–Darling test as it gives more weight to the tails of the distribution (that is close to the blood-myocardial interface which was of particular interest to us). Two-sided p-values < 0.05 were considered significant.
Intra- and inter-observer variability (absolute agreement) of T1 mapping times were assessed using two-way random, single measures intraclass correlation coefficient (ICC).
Results
Study population characteristics
Demographic and CMR characteristics of the 10 healthy volunteers (8 females, age 36 ± 10 years) are presented in Table 2.
Table 2.
Healthy volunteers (n = 10) | |
---|---|
Demographics | |
Age, years | 36 ± 10 |
Female | 8 (80%) |
Height, cm | 168.4 ± 8.7 |
Weight, kg | 71.6 ± 13.3 |
BSA, m2 | 1.8 ± 0.2 |
CMR parameters | |
LAVi, mL/m2 | 11.0 ± 2.1 |
RAVi, mL/m2 | 11.3 ± 1.3 |
LVEDVi, mL/m2 | 74.6 ± 0.2 |
LVESVi, mL/m2 | 27.6 ± 0.2 |
LVEF, % | 63 ± 5.1 |
MAPSE, mm | 15.3 ± 2.7 |
LV MWT, mm | 7.8 ± 1.0 |
LVMi, g/m2 | 48.3 ± 12.5 |
RVEDVi, mL/m2 | 75.1 ± 9.0 |
RVESVi, mL/m2 | 38.6 ± 9.9 |
RVEF, % | 49 ± 10.2 |
RVMi, g/m2 | 25.8 ± 4 |
TAPSE, mm | 25.3 ± 3.1 |
Data reported as mean ± 1SD or count (%) as appropriate
BSA, body surface area; CMR, cardiovascular magnetic resonance; LAVi, left atrial volume; LVEDVi, left ventricular end-diastolic volume indexed to body surface area; LVEF, left ventricular ejection fraction; LVESVi, left ventricular end-systolic volume indexed to body surface area; LVMi, left ventricular mass; MAPSE, mitral annular plane systolic excursion; MWT, maximum wall thickness; RAVi, right atrial volume; RVEDVi, right ventricular end-diastolic volume indexed to body surface area; RVEF, right ventricular ejection fraction; RVESVi, right ventricular end-systolic volume indexed to body surface area; SD, standard deviation; TAPSE, tricuspid annular plane systolic excursion
Feasibility in vivo
SAPPHIRE T1 mapping using all 4 variants was completed successfully in all subjects (Tables 3, 4), Each SAPPHIRE T1 map was acquired within a standard single breathold not dissimilar from a convetional MOLLI acquisition. ROI placement for RV T1 mapping was not feasible using MOLLI or diastolic SAPPHIRE because of insufficient wall thickness, but it was possible using systolic, 0th order and 2nd order DB SAPPHIRE and results are reported in Table 4
Table 3.
Sequence | Field Strength | Basal SAX | Mid SAX | Apical SAX | Mid Septal ROI | Global T1 | Non-apical Global T1 |
---|---|---|---|---|---|---|---|
MOLLI* | 1.5 T | 1032 ± 23 | 1029 ± 26 | 1030 ± 21 | 1037 ± 28 | 1034 ± 7 | 1031 ± 2 |
3 T | 1297 ± 27 | 1297 ± 26 | 1311 ± 32 | 1310 ± 36 | 1298 ± 9 | 1295 ± 3 | |
Diastolic SAPPHIRE | 1.5 T | 1261 ± 45 | 1267 ± 33 | 1342 ± 60 | 1250 ± 79 | 1284 ± 11 | 1264 ± 3 |
3 T | 1637 ± 83 | 1596 ± 48 | 1593 ± 70 | 1603 ± 53 | 1601 ± 17 | 1612 ± 6 | |
Systolic SAPPHIRE | 1.5 T | 1286 ± 51 | 1225 ± 21 | 1239 ± 18 | 1225 ± 42 | 1239 ± 9 | 1253 ± 5 |
3 T | 1580 ± 41 | 1586 ± 44 | 1596 ± 43 | 1585 ± 48 | 1596 ± 13 | 1591 ± 4 | |
DB 0th order SAPPHIRE | 1.5 T | 1229 ± 57 | 1248 ± 30 | 1246 ± 55 | 1228 ± 78 | 1241 ± 10 | 1242 ± 3 |
3 T | 1571 ± 69 | 1595 ± 46 | 1608 ± 42 | 1597 ± 74 | 1596 ± 12 | 1584 ± 5 | |
DB 2nd order SAPPHIRE | 1.5 T | 1235 ± 46 | 1225 ± 61 | 1298 ± 51 | 1220 ± 111 | 1251 ± 11 | 1237 ± 5 |
3 T | 1550 ± 65 | 1555 ± 64 | 1569 ± 31 | 1503 ± 132 | 1561 ± 20 | 1561 ± 4 |
Values reported are mean ± 1SD
*At our CMR Unit (the UCL Bloomsbury Center for Clinical Phenotyping) normal values for native myocardial T1 by MOLLI in healthy volunteers are 1030 ± 32 ms at 1.5 T and 1280 ± 46 ms at 3 T
DB, Dark blood; MOLLI, Modified Look-Locker inversion recovery; ROI, region of interest; SAPPHIRE, SAturation Pulse Prepared Heart-rate independent Inversion REcovery; SAX, short axis; T, Tesla. Other abbreviations as in Table 1
Table 4.
Sequence | Field Strength | Basal SAX (inferior or free wall) | Mid SAX (inferior wall) | Mid SAX (free wall) | Global T1 ROI |
---|---|---|---|---|---|
MOLLI* | 1.5 T | NA | NA | NA | NA |
3 T | NA | NA | NA | NA | |
Diastolic SAPPHIRE* | 1.5 T | NA | NA | NA | NA |
3 T | NA | NA | NA | NA | |
Systolic SAPPHIRE | 1.5 T | 1531 ± 94 | 1479 ± 98 | 1422 ± 58 | 1477 ± 83 |
3 T | 1766 ± 14 | 1757 ± 51 | 1769 ± 31 | 1764 ± 32 | |
DB 0th order SAPPHIRE | 1.5 T | 1440 ± 67 | 1453 ± 122 | 1453 ± 104 | 1448 ± 98 |
3 T | 1724 ± 37 | 1681 ± 43 | 1689 ± 49 | 1698 ± 43 | |
DB 2nd order SAPPHIRE | 1.5 T | 1524 ± 44 | 1417 ± 82 | 1452 ± 54 | 1464 ± 60 |
3 T | 1684 ± 101 | 1667 ± 63 | 1658 ± 78 | 1670 ± 81 |
Values reported are mean ± 1SD
*RV measurements were obtained only when the RV wall thickness ≥ 5 mm and this was not achievable with MOLLI or diastolic SAPPHIRE
DB, Dark blood; MOLLI, Modified Look-Locker inversion recovery; ROI, region of interest; RV, right ventricle; SAPPHIRE, SAturation Pulse Prepared Heart-rate independent Inversion REcovery; SAX, short axis; T, Tesla. Other abbreviations as in Table 1
Inter-field strength differences
Healthy volunteer native myocardial T1 times obtained by the 4 SAPPHIRE variants and by MOLLI across field strengths are reported in Table 3, and global LV T1 times provided in Fig. 5. As expected, for each sequence T1 times were consistently higher at 3 T than at 1.5 T (all p < 0.005, Fig. 6).
Differences between SAPPHIRE variants and MOLLI
Native myocardial T1 times by MOLLI for study members at either field strength matched the normal values by this sequence previously established at our center (reported in Table 3). As expected, from the known higher accuracy of saturation-based vs. inversion recovery-based T1 mapping sequences [20], the 4 SAPPHIRE variants measured longer global myocardial T1 times than MOLLI (pairwise comparisons all p < 0.005, Additional file 1: Table S1). These differences persisted after removing the apical slice data (Additional file 1: Table S2, p < 0.005).
Differences between SAPPHIRE variants
Using linear mixed models to adjust for field strength, phase, slice location and subject, myocardial T1 times by diastolic SAPPHIRE were significantly longer than with systolic, 0th order DB and 2nd order DB SAPPHIRE at 1.5 T and significantly longer than with systolic and 2nd order DB SAPPHIRE at 3 T (all p < 0.05, Fig. 7a). After excluding the apical slice the myocardial T1 times by diastolic SAPPHIRE were significantly longer than with systolic, 0th order DB and 2nd order DB SAPPHIRE at both field strengths (all p < 0.05, Fig. 7b).
At 1.5 T pairwise comparisons for LV global T1 showed that diastolic SAPPHIRE measured significantly longer T1 times than the 0th order DB SAPPHIRE (p = 0.014, Additional file 1: Table S1) but not after excluding the apical slice data (Additional file 1: Table S2). Pairwise comparisons of RV T1 times showed no differences between DB SAPPHIRE variants (all p > 0.005, Additional file 1: Table S3). At 3 T systolic SAPPHIRE measured significantly longer RV T1 times than the 0th order and 2nd order SAPPHIRE (p = 0.028 and 0.001, respectively) but no such differences were observed at 1.5 T (all p > 0.05).
Transmural T1 mapping profiles of MOLLI and SAPPHIRE variants
Figure 8a shows native T1 maps from MOLLI and the 4 SAPPHIRE variants. Transmural T1 times (Fig. 8b) in the mid septum immediately adjacent to the LV and RV blood pools were longer by MOLLI and diastolic SAPPHIRE when compared to systolic, 0th order DB and 2nd order DB SAPPHIRE. Contamination from the high T1 of the blood pool appeared as an upsloping T1 profile near the edges of the septal profile for both MOLLI and diastolic SAPPHIRE sequences, but not for the other SAPPHIRE variants. Indeed, the profile distributions of transmural myocardial T1 times by the Anderson–Darling test differed significantly between MOLLI and all 4 SAPPHIRE variants (diastolic p = 0.0003; systolic p = 0.0003; 0th order DB p = 0.024; 2nd order DB p = 0.025); between diastolic SAPPHIRE and both DB variants (0th order DB p = 0.0003; 2nd order DB p = 0.001); and between systolic SAPPHIRE and both DB variants (0th order DB p = 0.0003; 2nd order DB p = 0.0005), Furthermore, the dispersion of transmural T1 times across the mid septum for systolic (1233 ± 22 ms; interquartile range [IQR] = 25.3 ms) and DB SAPPHIRE variants (0th order: 1206 ± 46 ms; IQR = 71.0 ms | 2nd order: 1178 ± 52 ms; IQR = 72.9 ms) was narrower when compared to diastolic SAPPHIRE (1263 ± 86 ms; IQR = 142.8 ms), and the dispersion for systolic SAPPHIRE narrower than of MOLLI (1054 ± 42 ms; IQR = 56.4 ms).
Re-read variability of T1 mapping measurements
Intra- and interobserver variability of myocardial T1 reads was excellent across all sequences tested with ICCs ranging from 0.953–0.996 (Table 5).
Table 5.
Sequence | Region | Intra-observer ICC (95% CI) | Inter-observer ICC (95% CI) |
---|---|---|---|
MOLLI | Average mid | 0.989 (0.91–0.99) | 0.968 (0.76–0.99) |
Septal ROI | 0.978 (0.78–0.99) | 0.950 (0.53–0.99) | |
Diastolic SAPPHIRE | Average mid | 0.996 (0.45–0.99) | 0.993 (082–0.99) |
Septal ROI | 0.987 (0.89–0.99) | 0.954 (0.52–0.99) | |
Systolic SAPPHIRE | Average mid | 0.957 (0.64–0.99) | 0.953 (0.54–0.99) |
Septal ROI | 0.964 (0.66–0.99) | 0.982 (0.87–0.99) | |
0th order DB SAPPHIRE | Average mid | 0.994 (0.95–0.99) | 0.984 (0.50–0.99) |
Septal ROI | 0.991 (0.76–0.99) | 0.986 (0.84–0.99) | |
2nd order DB SAPPHIRE | Average mid | 0.973 (0.78–0.99) | 0.967 (0.47–0.99) |
Septal ROI | 0.994 (0.79–0.99) | 0.992 (0.88–0.99) |
Discussion
This study assessed the feasibility of biventricular SAPPHIRE T1 mapping in vivo across field strengths. We found that native T1 was significantly shorter by the systolic, 0th order DB and 2nd order DB SAPPHIRE variants compared to diastolic SAPPHIRE across field strengths. We show that systolic and DB SAPPHIRE variants reduce the dispersion of trans-myocardial T1 times across the septum and abolish the artefactual T1 lengthening in voxels located at the blood-myocardial/epicardial boundaries that remains a visible problem for both MOLLI and diastolic SAPPHIRE. Combined, these data suggest that systolic and DB SAPPHIRE approaches may help counteract the problem of partial volume effects. According to these data, the 0th and 2nd order DB SAPPHIRE sequences appear to be equivalent at preventing myocardial T1 signal contamination by the adjacent blood pool. Systolic SAPPHIRE was the sequence that produced the narrowest dispersion of myocardial T1 times across the mid septum.
Previous work at 3 T has suggested that native myocardial T1 in health lengthens progressively from base to apex [21, 22] and we observed a similar trend by MOLLI at 3 T but not at 1.5 T, and not with the majority of SAPPHIRE variants used in this study. The most likely explanation for the lengthening T1 from base to apex is that partial volume effects are more prevalent in the thinner more apical segments, and exacerbated by the natural curvature of the apical cap.
Results from linear mixed model analysis showing that native T1 was longer by diastolic than systolic SAPPHIRE at both field strengths, are in agreement with previous work [9, 11, 23, 24]. It has been postulated that in systolic T1 mapping these differences were due to reduced partial volume effects thanks to the increased LV wall thickness. The fact that 0th order and 2nd order DB SAPPHIRE T1 times were significantly shorter than diastolic SAPPHIRE suggests that blood pool suppression is another potential solution for the problem of partial volume effects.
We observed that the RV free wall was visible and indeed analysable on the short axis cine slices by systolic and DB SAPPHIRE approaches but hardly visible at all by conventional bright blood SAPPHIRE or MOLLI. We found that RV T1 was significantly longer than LV T1 which might be due to residual partial voluming and/or the naturally higher collagen content of the RV [25]. The published literature provides conflicting data on the relationship between RV and LV T1, with groups reporting higher RV T1 [26–28], lower RV T1[29] or equivalent RV/LV T1 reads [30] in various cohorts, not all of which were healthy controls as in our case. Although we took care to draw precise ROIs in the RV myocardium, partial voluming and contamination of RV T1 times from the inadvertent inclusion of voxels contaminated by blood pool or epicardial fat signals are plausible pitfalls that could have artefactually lengthened our native RV myocardial T1 times.
Overall, the evidence presented in this study suggests that systolic and DB approaches are less prone to partial volume effects than MOLLI and diastolic SAPPHIRE. The transeptal myocardial T1 times immediately adjacent to LV/RV blood pools recorded for 0th and 2nd order DB SAPPHIRE were significantly lower than those recorded for systolic SAPPHIRE (Fig. 8b) suggesting that blood pool nulling achieved by the DB T1 mapping approaches provides some additional benefit thanks to the reduced sensitivity to partial volume effects. Future work should continue to explore the potential clinical utility of DB SAPPHIRE T1 mapping for the study of thin-walled cardiac structures, such as the RV free wall, atria an apical slices.
We report excellent intra- and inter-observer re-read reproducibility for all the methods studied with all ICCs (> 0.90) being well in line with previous reports [8, 21, 23, 24, 31–34].
In this study we also demonstrate the use of higher order gradient moment nulling for dark blood T1 mapping. In previous literature 0th order nulling was found to be susceptible to residual myocardial motion in some cases, necessitating fine tuning of the motion sensitising gradient moment. As the residual cardiac motion is less turbulent compared to blood flow, stronger motion sensitizing gradients may be applied when nulling the gradient moment up to the 2nd order. Even though quantification results were comparable between 0th and 2nd order DB SAPPHIRE in our experiments, 2nd order nulling may have the advantage of increased ease of use for clinical translation. Robustness of higher order gradient nulling for DB T1 mapping, thus, warrants further investigation in a patient cohort.
Limitatons
This small-scale single-center, single-vendor feasibilty study include small numbrer of healthy volunteers, the results hold promise to overcome some conventional T1 mapping limitations. Further work with larger cohorts in health and disease are needed to explore the robustness and validation. The establishment of normal values for T1 by SAPPHIRE was beyond the scope of this study.
Comparison to other T1 mapping sequences besides MOLLI was not undertaken and neither was post-contrast T1 mapping. Future work will need to examine the clinical utility of these SAPPHIRE sequences in patients with arrhythmia, cardiomyopathy and for the study of other thin-walled cardiac structures such as the atria. RV T1 analysis was not possible on MOLLI or diastolic SAPPHIRE due to the RV thickness limitation. MOCO was used for MOLLI sequences but not for the SAPPHIRE T1 mapping sequences. Future work should seek to assess the impact of heart rate (HR) variability on the spin dynamic in the systolic SAPPHIRE sequence. This study was not specifically designed to examine the impact of HR on the quality of systolic data, nevertheless we had a broad range of resting HRs across study members (from 56 to 89 bpm). We observed good quality raw systolic images and reconstructed maps regardless of HR (Additional file 1: Figure S1).
Further testing and validation of the systolic SAPPHIRE sequence will be needed to understand its robustness in relation to RV T1 mapping, but our preliminary findings at least indicate that systolic SAPPHIRE T1 mapping permits placement of a decent-sized ROI in the RV free wall, otherwise impossible with conventional T1 mapping approaches.
Conclusion
These small-scale preliminary healthy volunteer data suggest that DB SAPPHIRE has the potential to reduce partial volume effects at the blood-myocardial interface, and that systolic SAPPHIRE could be a feasible solution for right ventricular T1 mapping. Further work is needed to understand the robustness of these sequences and their potential clinical utility.
Supplementary Information
Acknowledgements
Not applicable.
Abbreviations
- BSA
Body surface area
- bSSFP
Balanced steady-state free precession
- CI
Confidence interval
- CMR
Cardiovascular magnetic resonance
- CVI42
Circle Cardiovascular Imaging 42
- DB
Dark-blood
- ECG
Electrocardiogram
- FA
Flip angle
- HR
Heart rate
- ICC
Intraclass correlation coefficient
- LAVi
Left atrial volume indexed to body surface area
- LV
Left ventricle
- LVEDVi
Left ventricular end-diastolic volume indexed to body surface area
- LVEF
LV ejection fraction
- LVESVi
Left ventricular end-systolic volume indexed to body surface area
- LVMi
Left ventricular mass indexed to body surface area
- MAPSE
Mitral annular plane systolic excursion
- MOCO
Motion correction
- MOLLI
Modified look-locker inversion recovery
- MSDE
Motion sensitized driven equilibrium
- MWT
Maximum wall thickness
- NIHR RD-TRC
National institute for health research rare diseases translational research collaboration
- RAVi
Right atrial volume indexed to body surface area
- ROI
Region of interest
- RV
Right ventricle
- RVEDVi
Right ventricular end-diastolic volume indexed to body surface area
- RVEF
Right ventricular ejection fraction
- RVESVi
Right ventricular end-systolic volume indexed to body surface area
- SAPPHIRE
Saturation-pulse prepared heart-rate independent inversion-recovery
- SAX
Short axis
- SD
Standard deviation
- T
Tesla
- TAPSE
Tricuspid annular plane systolic excursion
- TD
Trigger delay
- TI
Inversion time
- TR/TE
Time between two consecutive excitations/echo time
- UCL
University College London
Author contributions
M.A. analysed the data, performed the statistical analysis and wrote the manuscript. J.B.A., K.D.K. and G.C. collected and acquisitioned the data. J.B.A., K.D.K., N.F., P.K.M. and S.W. contributed to data analysis and review of the manuscript. R.B., A.D.H. and J.C.M. have substantially revised the manuscript. G.C., S.W. and J.C.M. conceived of the project. All authors have read and approved the submitted version and all other substantially modified versions. All authors have agreed both to be personally accountable for their own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature. All authors read and approved the final manuscript.
Funding
This study was funded by the 2017 Society of Cardiovascular Magnetic Resonance Seed Grant Award to G.C. The funding body had no role in the design of the study or in the collection, analysis, and interpretation of data or in writing the manuscript. M.A. is supported by Saudi Arabian Cultural Bureau in London. G.C. is supported by the British Medical Association Josephine Lansdell research grant, by the British Heart Foundation (MyoFit46 Special Programme Grant SP/20/2/34841), the National Institute for Health Research Rare Diseases Translational Research Collaboration (NIHR RD-TRC) and by the NIHR UCL Hospitals Biomedical Research Center. J.C.M. is directly and indirectly supported by the UCL Hospitals NIHR BRC and Biomedical Research Unit at Barts Hospital respectively. S.W. acknowledges grant support by the 4TU Federation, NWO Startup and ZonMW OffRoad. The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Declarations
Ethics approval and consent to participate
The study received ethical approval from the University College London (UCL) Research Ethics Committee. All subjects provided written informed consent.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Dweck MR, Joshi S, Murigu T, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58:1271–1279. doi: 10.1016/j.jacc.2011.03.064. [DOI] [PubMed] [Google Scholar]
- 2.Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309:896–908. doi: 10.1001/jama.2013.1363. [DOI] [PubMed] [Google Scholar]
- 3.Wong TC, Piehler K, Meier CG, et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation. 2012;126:1206–1216. doi: 10.1161/CIRCULATIONAHA.111.089409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wong TC, Piehler KM, Kang IA, et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J. 2014;35:657–664. doi: 10.1093/eurheartj/eht193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Vassiliou VS, Perperoglou A, Raphael CE, et al. Midwall fibrosis and 5-year outcome in patients with moderate and severe aortic stenosis. J Am Coll Cardiol. 2017;69:1755–1756. doi: 10.1016/j.jacc.2017.01.034. [DOI] [PubMed] [Google Scholar]
- 6.Radenkovic D, Weingärtner S, Ricketts L, Moon JC, Captur G. T1 mapping in cardiac MRI. Heart Fail Rev. 2017;22(4):415–430. doi: 10.1007/s10741-017-9627-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson. 2014;16:2–12. doi: 10.1186/1532-429X-16-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Weingärtner S, Meßner NM, Zöllner FG, Akçakaya M, Schad LR. Black-blood native T1mapping: blood signal suppression for reduced partial voluming in the myocardium. Magn Reson Med. 2017;78:484–493. doi: 10.1002/mrm.26378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ferreira VM, Wijesurendra RS, Liu A, Greiser A, Casadei B, Robson MD, Neubauer S, Piechnik SK. Systolic ShMOLLI myocardial T1-mapping for improved robustness to partial-volume effects and applications in tachyarrhythmias. J Cardiovasc Magn Reson. 2015;17:77–85. doi: 10.1186/s12968-015-0182-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Meßner NM, Budjan J, Loßnitzer D, Papavassiliu T, Schad LR, Weingärtner S, Zöllner FG. Saturation-recovery myocardial t1-mapping during systole: accurate and robust quantifcation in the presence of arrhythmia. Sci Rep. 2018;8:5251–5260. doi: 10.1038/s41598-018-23506-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Zhao L, Li S, Ma X, Greiser A, et al. Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation. J Cardiovasc Magn Reson. 2016;18:13–23. doi: 10.1186/s12968-016-0232-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Captur G, Bhandari A, Brühl R, et al. T1 mapping performance and measurement repeatability: results from the multi-national T1 mapping standardization phantom program (T1MES) J Cardiovasc Magn Reson. 2020;22:31–41. doi: 10.1186/s12968-020-00613-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang Y, Vidan E, Bergman GW. Cardiac motion of coronary arteries: variability in the rest period and implications for coronary MR angiography. Radiology. 1999;213:751–758. doi: 10.1148/radiology.213.3.r99dc41751. [DOI] [PubMed] [Google Scholar]
- 14.Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardised cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15:91–110. doi: 10.1186/1532-429X-15-91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging. 2003;17:323–329. doi: 10.1002/jmri.10262. [DOI] [PubMed] [Google Scholar]
- 16.Doesch C, Lossnitzer D, Rudic B, et al. Right ventricular and right atrial involvement can predict atrial fibrillation in patients with hypertrophic cardiomyopathy? Int J Med Sci. 2016;13:1–7. doi: 10.7150/ijms.13530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zareian M, Ciuffo L, Habibi M, et al. Left atrial structure and functional quantitation using cardiovascular magnetic resonance and multimodality tissue tracking: validation and reproducibility assessment. J Cardiovasc Magn Reson. 2015;17:52–56. doi: 10.1186/s12968-015-0152-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Captur G, Lopes LR, Patel V, et al. Abnormal cardiac formation in hypertrophic cardiomyopathy: fractal analysis of trabeculae and preclinical gene expression. Circ Cardiovasc Genet. 2014;7:241–248. doi: 10.1161/CIRCGENETICS.113.000362. [DOI] [PubMed] [Google Scholar]
- 19.Weingärtner S, Akçakaya M, Basha T, et al. Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn Reson Med. 2014;71:1024–1034. doi: 10.1002/mrm.24761. [DOI] [PubMed] [Google Scholar]
- 20.Roujol S, Weingärtner S, Foppa M, et al. Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology. 2014;272:683–689. doi: 10.1148/radiol.14140296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer MA, et al. Myocardial T1 and T2 mapping at 3T: reference values, influencing factors and implications. J Cardiovasc Magn Reson. 2013;15:53–60. doi: 10.1186/1532-429X-15-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Dong Y, Yang D, Han Y, et al. Age and gender impact the measurement of myocardial interstitial fibrosis in a healthy adult chinese population: a cardiac magnetic resonance study. Front Physiol. 2018;9:140–150. doi: 10.3389/fphys.2018.00140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson. 2012;14:27–35. doi: 10.1186/1532-429X-14-27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Reiter U, Reiter G, Dorr K, Greiser A, Maderthaner R, Fuchsjäger M. Normal diastolic and systolic myocardial T1 values at 1.5-T MR imaging: correlations and blood normalization. Radiology. 2014;271:365–372. doi: 10.1148/radiol.13131225. [DOI] [PubMed] [Google Scholar]
- 25.Oken DE, Boucek RJ. Quantitation of collagen in human myocardium. Circ Res. 1957;5:357–361. doi: 10.1161/01.RES.5.4.357. [DOI] [PubMed] [Google Scholar]
- 26.Kawel-Boehm N, Dellas Buser T, Greiser A, Bieri O, Bremerich J, Santini F. In-vivo assessment of normal T1 values of the right-ventricular myocardium by cardiac MRI. Int J Cardiovasc Imaging. 2014;30:323–328. doi: 10.1007/s10554-013-0326-3. [DOI] [PubMed] [Google Scholar]
- 27.Secchi F, Alì M, Monti CB, Greiser A, Pluchinotta FR, Carminati M, Sardanelli F. Right and left ventricle native T1 mapping in systolic phase in patients with congenital heart disease. Acta Radiol. 2021;62:334–340. doi: 10.1177/0284185120924563. [DOI] [PubMed] [Google Scholar]
- 28.Karur GR, Robison S, Iwanochko RM, et al. Use of myocardial t1 mapping at 3.0 t to differentiate anderson-fabry disease from hypertrophic cardiomyopathy. Radiology. 2018;288:398–406. doi: 10.1148/radiol.2018172613. [DOI] [PubMed] [Google Scholar]
- 29.Wang J, Zhao H, Wang Y, Herrmann HC, Witschey WRT, Han Y. Native T1 and T2 mapping by cardiovascular magnetic resonance imaging in pressure overloaded left and right heart diseases. J Thoracic Dis. 2018;10:2968–2975. doi: 10.21037/jtd.2018.04.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Mehta BB, Auger DA, Gonzalez JA, et al. Detection of elevated right ventricular extracellular volume in pulmonary hypertension using accelerated and navigator-gated look-locker imaging for cardiac T1 estimation (ANGIE) cardiovascular magnetic resonance. J Cardiovasc Mag Res. 2015;17:110–120. doi: 10.1186/s12968-015-0209-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Chin CW, Semple S, Malley T, et al. Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging. 2014;15:556–565. doi: 10.1093/ehjci/jet245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6:475–484. doi: 10.1016/j.jcmg.2012.08.019. [DOI] [PubMed] [Google Scholar]
- 33.Vassiliou V, Heng EL, Sharma P, et al. Reproducibility of T1 mapping 11-heart beat MOLLI Sequence. J Cardiovasc Magn Reson. 2015;17:W26. doi: 10.1186/1532-429X-17-S1-W26. [DOI] [Google Scholar]
- 34.Weingärtner S, Meßner NM, Budjan J, et al. Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI. J Cardiovasc Magn Reson. 2017;18:84–90. doi: 10.1186/s12968-016-0302-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.